AI assistant
Sending…
PETMED EXPRESS INC — Director's Dealing 2018
Jan 16, 2018
34556_dirs_2018-01-16_4ed4879a-38c1-4cd4-a1b4-4357c80be763.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PETMED EXPRESS INC (PETS)
CIK: 0001040130
Period of Report: 2018-01-11
Reporting Person: AKDAG MENDERES (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-11 | Common Stock | S | 30000 | $51 | Disposed | 490000 | Direct |
| 2018-01-12 | Common Stock | S | 10000 | $53 | Disposed | 480000 | Direct |
Footnotes
F1: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.
More from PETMED EXPRESS INC
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
Feb 11
Interim / Quarterly Report
2026
Feb 5
Regulatory Filings
2026
Jan 23
Director's Dealing
2026
Jan 23
Interim / Quarterly Report
2025
Dec 19
Interim / Quarterly Report
2025
Dec 19
Major Shareholding Notification
2025
Dec 11
Proxy Solicitation & Information Statement
2025
Dec 10
Regulatory Filings
2025
Dec 9